Namjin Cho’s research while affiliated with POSTECH POHANG UNIVERSITY OF SCIENCE AND TECHNOLOGY and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (4)


Expanding the Scope of Ribosome‐Mediated Biosynthesis in vitro using tRNA‐Aminoacylating Ribozyme
  • Article

June 2024

·

5 Reads

·

2 Citations

Israel Journal of Chemistry

Namjin Cho

·

Haneul Jin

·

Hyewon Jeon

·

[...]

·

Joongoo Lee

Proteins are synthesized within ribosomes through the polymerization of amino acids (AAs). This process requires prior activation of AAs through aminoacylation that attaches them to their corresponding transfer RNAs (tRNAs). Within cells, this attachment is facilitated by aminoacyl‐tRNA synthetase, resulting in a tRNA:AA conjugate. A set of ribozymes developed to acylate tRNA with non‐canonical substrates enables this process outside the confines of living cells, thereby facilitating the synthesis of novel bio‐based products. In modern biotechnology, aminoacylating ribozymes contribute to the production of innovative bio‐based materials bearing functional non‐canonical chemical substrates (NCSs) and fill the gaps in synthesizing unique polymeric backbones, extending the scope beyond traditional peptide bonds. This review summarizes current understanding of flexizymes at the molecular level and their application in generating exceptional polymeric backbones through ribosome‐mediated synthesis in vitro .


Fig. 1. An overview of peptidomimetics synthesis. (A) Biomanufacturing of peptide drugs. Initially, drugs were directly purified from animals, and later obtained using chemical and biological syntheses. Peptide drugs were commonly produced using either in vivo or in vitro biological systems. (B) Recently, the open environment of cell-free protein synthesis (CFPS) has been used for new drug discovery. CFPS integrated with high-throughput analysis techniques (display and mass spectrometry) enables screening of affinity peptidomimetic molecules that bind to a target protein from a vast peptide library.
Fig. 2. Fx-mediated acylation produces a tRNA:substrate complex like those made in cells by aaRSs. For the site-specific incorporation of non-canonical substrate into a polymeric chain, a tRNA:substrate complex must be formed before it is accepted by the ribosome. Fx catalyzes the acylation of non-canonical substrates activated with esters to the 3'-OH of a tRNA. Fx: flexizyme, tRNA: transfer RNA, aaRS: aminoacyl-tRNA synthetases.
Fig. 3. An overview of display technologies used to select peptide-based molecules binding to target proteins with high affinity. (A) Selection platforms that display peptides on the surface of living systems (phage display and cell-surface display). (B) A schema of in vitro selection platforms widely used for drug discovery. A large number of macrocyclic peptidomimetics has been discovered using the RaPID system, which integrate the CFPS platform, Fx technology, and mRNA display. The selected phenotypes are identified through the genetic template that are covalently linked to the phenotype. RaPID: Random non-canonical Peptide Integrated Discovery, CFPS: cell-free protein synthesis, Fx: flexizyme.
Fig. 7. A peptidomimetic binder molecule discovered by AS-MS integrating mass-spectrometric analysis with high-throughput technology. From a random peptide library, ABP-1 was found to bind to ACE2 proteins with nanomolar affinity (K D = 19 nM). The residues in red are non-canonical building blocks. AS-MS: affinity selection-mass spectrometry, ACE2: angiotensin converting enzyme 2.
Fig. 10. Ribosome evolution platforms. (A) iSAT. T7-transcripts of 23S, 16S, and 5S rRNA are produced from DNA templates and assembled into active ribosomes with TP70 r-proteins. (B) RISE selects mutant ribosomes from a random DNA library by capturing mutants capable of synthesizing desired polymers. iSAT: in vitro synthesis, assembly, and translation, RISE: in vitro methodology for ribosome synthesis and evolution.
Cell-free Biosynthesis of Peptidomimetics
  • Literature Review
  • Full-text available

February 2023

·

77 Reads

·

8 Citations

Biotechnology and Bioprocess Engineering

A wide variety of peptidomimetics (peptide analogs) possessing innovative biological functions have been brought forth as therapeutic candidates through cell-free protein synthesis (CFPS) systems. A key feature of these peptidomimetic drugs is the use of non-canonical amino acid building blocks with diverse biochemical properties that expand functional diversity. Here, we summarize recent technologies leveraging CFPS platforms to expand the reach of peptidomimetics drugs. We also offer perspectives on engineering the translational machinery that may open new opportunities for expanding genetically encoded chemistry to transform drug discovery practice beyond traditional boundaries.

Download

Programmable Synthesis of Biobased Materials Using Cell‐Free Systems

November 2022

·

277 Reads

·

8 Citations

Motivated by the intricate mechanisms underlying biomolecule syntheses in cells that chemistry is currently unable to mimic, researchers have harnessed biological systems for manufacturing novel materials. Cell‐free systems (CFSs) utilizing the bioactivity of transcriptional and translational machineries in vitro are excellent tools that allow supplementation of exogenous materials for production of innovative materials beyond the capability of natural biological systems. Herein, recent studies that have advanced the ability to expand the scope of biobased materials using CFS have been summarized and approaches enabling the production of high‐value materials, prototyping of genetic parts and modules, and biofunctionalization have been discussed. By extending the reach of chemical and enzymatic reactions complementary to cellular materials, CFSs provide new opportunities at the interface of materials science and synthetic biology. This article is protected by copyright. All rights reserved


Ribosome-catalyzed formation of pyridazinone bonds in vitro
Genetic code reprogramming using the flexizyme system enables the acylation of non-canonical substrates with tRNA. Upon flexizyme-mediated tRNA acylation of keto (orange) and hydrazino (green) activated esters, the programmed keto-tRNA (orange) and hydrazinyl-tRNA (green) were added to an in vitro transcription and translation platform using purified components and allowed to decode two consecutive codons programmed on an mRNA strand. The translation mixture produced a pyridazinone bond (pink). For comparison, the typical peptide bond (red) is shown on the right. Fx flexizyme, AG activating group, CME cyanomethyl ester, DNB dinitrobenzylester, and ABT amino-derivatized benzylthio ester.
Design of γ-keto and hydrazino esters and ribosome-mediated synthesis of pyridazinone bonds
A Four γ-keto (orange) and B two hydrazino (green) esters were synthesized with an activated leaving group (CME, DNB, and ABT). DNB or ABT were used for the substrates that do not contain an aromatic moiety and the ABT-activated substances were only synthesized when the DNB substrates were found to be water-insoluble (Supplementary Information; 1-CME, 2-CME, 3-DNB, 3-ABT, 4-DNB; 5-CME, 6-DNB, 6-ABT). The substrates were charged to tRNA by the appropriate Fx and introduced to an in vitro translation reaction containing wild-type ribosomes. C In vitro translation reactions were carried out with pairs of γ-keto ester substrates (A) and hydrazino ester substrates (B). Ribosome-catalyzed synthesis of eight different pyridazinone rings was observed. The relative percent yield of the target oligomer of all species was determined by the peak area corresponding to the theoretical mass/the sum of areas of the whole peaks shown in the mass spectrum, as shown in matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) mass spectra (Supplementary Information). Percent yield is based on n = 3 reactions. D, E MALDI-TOF mass spectra of oligomers polymerized by the ribosome in vitro with a pyridazinone bond formed between 1 and 5, and 1 and 6, respectively. The calculated masses of the products in D are [M + H]⁺ = 1362, [M + Na]⁺ = 1384 and in E are [M + H]⁺ = 1286, [M + Na]⁺ = 1308. See SI for MALDI-TOF mass spectra of the other pyridazinone bonds represented in C. The non-target products at masses 1058 and 1080 (#) and 1305 and 1327 (*) are a reporter strep-tag alone (TrpSerHisProGlnPheGluLys) and the peptide containing a misincorporated Ser60,61 at the Thr (ACC) codon (1(Ser)TrpSerHisProGlnPheGluLys, see Supplementary Fig. 2 for details). Spectra in D and E are representative of n = 3 independent experiments.
The ribosome is required for pyridazinone formation under in vitro translation conditions
A The in vitro polymerization reaction was conducted using the same conditions that produced an N-terminal pyridazinone bond in an oligomer, but without the presence of ribosomes. In the deconvoluted mass spectra, the compounds having a molar mass of 179.0701 and 181.1017 were observed as a single peak at 4.4 and 3.6 min, which corresponds to 4-oxo-4-phenylbutanoic acid (orange in B) aminophenylalanine (green in C) hydrolyzed from tRNAfMet(CUA) and tRNAPro1E2(GGU), respectively. D No species corresponding to the theoretical mass of OPDP (322.1317) were observed in the reaction mixture. The extracted ion chromatograms were obtained based on theoretical average masses (Supplementary Information). Spectra are representative of n = 3 independent experiments.
Ribosomal synthesis of alternating copolymers with a pyridazinone backbone
A We designed an additional amino acid, γKPheA (7), bearing a ketone on its γ-carbon of the sidechain, for sequential polymerization of pyridazinones bonds on a biopolymer chain. Compounds 7 and 6 were charged to tRNAPro1E2(GGU) and tRNAGluE2(GAU) by flexizyme, respectively, and added to an in vitro transcription and translation reaction. The genetic template was designed to consecutively incorporate the monomers in an alternating fashion (ABAB- or ABABAB-type). The resulting peptides-pyridazinone hybrids were purified via the streptavidin tag (WSHPQFEK) and characterized by MALDI-TOF mass spectrometry. B MALDI mass spectrum of the StrepII-7676 peptide (relative peak area: 14.8%) and its molecular structure, calculated mass: [M + H]⁺ = 1791; [M + Na]⁺ = 1813 (C) MALDI mass spectrum of the StrepII-767676 (relative peak area: 16.9%) peptide and its molecular structure, calculated mass: [M + H]⁺ = 2034; [M + Na]⁺ = 2056. Spectra are representative of n = 3 independent experiments.
Ribosome-mediated biosynthesis of pyridazinone oligomers in vitro

October 2022

·

101 Reads

·

15 Citations

The ribosome is a macromolecular machine that catalyzes the sequence-defined polymerization of L-α-amino acids into polypeptides. The catalysis of peptide bond formation between amino acid substrates is based on entropy trapping, wherein the adjacency of transfer RNA (tRNA)-coupled acyl bonds in the P-site and the α-amino groups in the A-site aligns the substrates for coupling. The plasticity of this catalytic mechanism has been observed in both remnants of the evolution of the genetic code and modern efforts to reprogram the genetic code (e.g., ribosomal incorporation of non-canonical amino acids, ribosomal ester formation). However, the limits of ribosome-mediated polymerization are underexplored. Here, rather than peptide bonds, we demonstrate ribosome-mediated polymerization of pyridazinone bonds via a cyclocondensation reaction between activated γ-keto and α-hydrazino ester monomers. In addition, we demonstrate the ribosome-catalyzed synthesis of peptide-hybrid oligomers composed of multiple sequence-defined alternating pyridazinone linkages. Our results highlight the plasticity of the ribosome’s ancient bond-formation mechanism, expand the range of non-canonical polymeric backbones that can be synthesized by the ribosome, and open the door to new applications in synthetic biology. Ribosomes have evolved to polymerize L-α-amino acids into proteins comprising a peptide backbone. Here, a pyridazinone backbone is formed using ribosomes in vitro, producing a variety of sequence-defined alternating block-copolymers.

Citations (3)


... These minimal systems provide a highly customizable, highly controllable environment to characterize proteins particularly by light microscopy-based techniques, and will hence be easy to adapt for other emergent protein functions. Furthermore, we show that cell-free protein expression systems, which have recently become a vital technique in synthetic biology as they can deliver various peptide/protein libraries 26 for prototyping in a rapid and easy manner, can significantly speed up the experimental screening process. ...

Reference:

Machine learning-aided design and screening of an emergent protein function in synthetic cells
Cell-free Biosynthesis of Peptidomimetics

Biotechnology and Bioprocess Engineering

... 43 The first two groups of PBAs, AMPs and RiPPs, are synthesised by the translation apparatus while the third group includes non-ribosomally synthesised peptides produced by complex enzymatic processes mediated by the non-ribosomal peptide synthetases (NRPSs), which are large multi-modular enzyme complexes that catalyse the incorporation of diverse non-canonical substrates (D-amino acids, β-amino acids, hydroxyacids etc.) generating peptides with unique structures and efficacy. 41 Moreover, an innovative method to generate peptides with ncAAs is the Flexyzyme system that allows tRNA aminoacylation for the translation apparatus 44 consisting in artificial ribozymes generating mis-acylated tRNA enabling ncAAs incorporation during in vitro translation 45,46 leading, for instance, to the potential discovery of pseudo-natural macrocyclic peptides. 47 A CFPS platform of the pathogenic bacterium K. pnemoniae was conceived to contrast the rise of AMR. ...

Ribosome-mediated biosynthesis of pyridazinone oligomers in vitro

... Cell-free synthesis systems emerge as a promising solution in this scenario [14][15][16][17]. They enable the direct expression of genes from linear DNA without living cells, offering a flexible and controllable platform for swiftly developing enzymatic pathways. ...

Programmable Synthesis of Biobased Materials Using Cell‐Free Systems